Xsphera Biosciences is a biotechnology startup that focuses on delivering functional, precision immuno-oncology solutions.
Xsphera Biosciences has raised $12.6M in total funding. The most recent round was Series A. The last funding was announced in May 2023.
Xsphera Biosciences's investors include Aquila Capital Partners.
Xsphera Biosciences is headquartered in Boston, United States.
Xsphera Biosciences is a biotechnology startup that focuses on delivering functional, precision immuno-oncology solutions.
Xsphera Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xsphera Biosciences — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/xsphera-biosciences. Accessed October 30, 2026.
VCBacked. (2023). Xsphera Biosciences — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/xsphera-biosciences
{{cite web |title=Xsphera Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/xsphera-biosciences |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated